SlideShare une entreprise Scribd logo
1  sur  37
ORAL CANCER
SOYEBO O.A.
Den/2005/075
OUTLINE
• INTRODUCTION.
• DEFINITION.
• EPIDEMIOLOGY.
• ORAL CANCER AND PRECANCER
• RISK FACTORS.
• PREVENTION, DIAGNOSIS AND MANAGEMENT
• CONCLUSION
INTRODUCTION
• Oral cancer is one of the ten most
common malignancies in the world
• In developing countries it constitutes
the 3rd commonest malignancy
• Sites: lips and other intra-oral sites
but Para-oral sites such as the
salivary glands, the oropharynx,
nasopharynx and hypopharynx are
not normally included
DEFINITION
• Neoplasm: an abnormal tissue that grows by
cellular proliferation more rapidly than normal
tissue and continues to grow after the stimuli
that initiated the new growth cease.
• Neoplasm show partial or complete lack of
structural organization and functional
coordination with the normal tissue.
• Cancer – general term for malignant neoplasm
EPIDEMIOLOGY
• It is one of the ten most common malignancies
in the world.
• In Asia however, it accounts for over 40% of all
cancers
• Although there is paucity of data on the
epidemiology of the disease in Nigeria, an
increase in the number of oral cancer cases
reporting to general specialist and teaching
hospitals has been observed.
• Over 80% of the malignant neoplasm of the oro-
facial region are squamous cell carcinomas of the
oral mucosa, tongue and lip.
• It usually occurs in people above 40yrs of age
though, in high prevalent areas such as India,
Brazil, New Guinea, France and in Western
Europe, where the teenagers use oral snuff, the
incidence of oral cancer has been recorded in
people below the ages of 35yrs.
• Males are often affected more than females
ORAL CANCER AND PRECANCER
• Oral cancer: lips and other intra-oral sites.
– In the biology of oral cancer, it is now accepted that
series of discrete events take place which eventually
summate to form invasive neoplasm
– During oral carcinogenesis, aetiological factors may
damage cells at the level of DNA
– We can therefore assume that most if not all oral
cancers develop from cells which have survived a
succession of insults at the gene level and that in a
proportion of cases there may be distinguishing at
the clinical and histological level which indicate
precancerous change
• The WHO defined a precancerous lesion as
– “a generalized state associated with a significant
increased risk of cancer”
• Leukoplakia and Erythroplakia constitute the
important precancerous lesions
• Leukoplakia: a white patch or plaque that
cannot be rubbed off and cannot be
characterized clinically or histologically as any
other disease.
– It must in addition not be associated with any
physical or chemical causative agent except the
use of tobacco.
• Erythroplakia: a red patch that cannot be
characterized histologically or clinically as due
to any other condition.
– It is far less common than leukoplakia but it has a
higher malignant potential.
RISK AREAS
• Floor of the mouth
• Lateral border of the tongue
• Lower buccal sulcus
• Alveolus
• Angle of the mouth
PRECANCEROUS LESIONS PRECANCEROUS CONDITIONS
Leukoplakia
Erythroplakia
Syphilis
Sideropenic dysphagia
Submucous fibrosis
Lichen planus
Discoid lupus erythematosus
Actinic keratosis
Sublingual keratosis
RISK FACTORS
• Tobacco
• Alcohol
• Diet and Nutrition
• Ultraviolet light
• Fungal and Viral infection
• Habits
• Chronic Irritation
• Immunodeficiency/ Suppression
• Occupational Risk
TOBACCO
• Major source of intra-oral carcinogen.
• All forms of tobacco consumption have been linked.
– South east Asia: bethel quid
– North Africa and Middle East: a mixture of Tobacco
and lime water or oil called naswar or nash
– It could be held in the mouth
– Smoked in crude cigars or factory made cigarettes
• Carcinogens in tobacco: Nitrosamine (nicotine), the polycyclic
aromatic hydrocarbons (3,4-benzopyrene)
ALCOHOL
• 2nd major risk factor
• Associated with cancer of the floor of the mouth
and tongue.
• Excess consumption of EVERY TYPE of alcohol
(including “hard” liquor, wine, and Beer) raises
the risk status of oral cancer
• Potentiates the effects of tobacco
• Mechanism(s)
• Dehydrating effects of alcohol on the mucosa,
• increasing mucosal permeability,
• Irritation of mucosa
• and it also acts as a solvent for carcinogens
(especially those in tobacco)
DIET AND NUTRITION
• Deficiency of vitamin C, vitamin E , beta
carotene is a precursor of vitamin A and
vitamin A has been linked to oral cancer.
• Adequate consumption of raw vegetables and
fresh fruits gives a lower risk of oral and
pharyngeal cancer.
• Mechanism: Atrophy of oral mucosa
membrane.
• This render them more susceptible to
carcinogens.
ULTRAVIOLET LIGHT
• Causes
– Basal cell carcinoma of the skin
– carcinoma of the vermilion border of the lips
especially in people with outdoor occupation.
• Affects men more.
FUNGAL INFECTION
• Candida albicans has been implicated in oral
squamous cell carcinoma.
• Also found in oral red and white patches with
malignant potentials.
• Mechanisms
– Production of enzymes which produce genotoxic
metabolites
– Its hyphae carrying oncogenes like Ras
VIRAL INFECTION
• Human papilloma virus types 16 and 18
• Epstein Barr virus (naso-pharyngeal
carcinoma)
HABITS
• Chewing of betel quids and areca nuts,
especially when mixed with tobacco increases
the risk of developing oral cancer.
• Areca has been associated with the
development of Submucous fibrosis
• Use of clay pipe has been associated with lip
cancer (thermal irritation)
CHRONIC IRRITATION
• It is possible that chronic trauma, in addition
to other carcinogens, may promote the
transformation of epithelial cells.
• Dental calculus, ill fitting dentures, jagged
edges of restorations may play a role in
localizing the site of tumor development.
IMMUNE DEFICIENCY/
SUPPRESSION
• It could b drug induced or as a result of HIV
infection which could render patients
susceptible to oncogenic viruses
• However a definite relationship between
immune suppression and oral cancer is yet to
be established.
OCCUPATIONAL RISK
• Plays a minor role
• Exposure to the following have been associated
with oropharyngeal and laryngeal cancer;
– Cement
– Coal products
– Wood dust
– Organic chemicals
– Nickel dust
• Occupational exposure to Ultraviolet rays from
sunlight has been associated with cancer of the
lips
DIAGNOSIS
• Diagnosis of oral cancer and precancer depends
on the medical and dental history and clinical
examination supplemented by investigations
• Any chronic oral lesion should be regarded with
suspicion especially in an older patient or
associated with any of the precancerous lesions
and conditions outlined below
• Extra caution must also be taken if lesion is
indurated, fixed, attached to the underlying
tissue, associated with lymphadenopathy.
Prognostic factors
• Tumor size: <2cm
• Depth of infiltration: <5mm
• Site : lips > oral cavity > oropharynx
• Lymph nodes: presence of clinically positive or
fixed lymph nodes gives worse prognosis
PREVENTION.
• Prevention involves interventions aimed at
eliminating, eradicating or minimizing the
impact of the disease
• PRIMORDIAL
• Avoid the emergence and establishment of the
patterns of living that are known to contribute to
an elevated risk of disease
• PRIMARY: Reduce the incidence of cancer and
precancer.It is aimed reducing the number of new cases.
– Discourage smoking and alcohol consumption
– Encourage good oral hygiene
– Encourage balanced diet
– Use of hat in sunlight for farmers
– Wearing of facemasks for factory workers
involved with chemicals and metals
– Health education
PREVENTION.
• SECONDARY: aimed at detection of cancer at
an early stage
• Early detection, especially at the
precancerous stage, offers a better prognosis
with a better chance of cure.
› Public education on early signs and self
examination
› Screening
PREVENTION.
• TERTIARY: Treat late stage of disease and
complications
MANAGEMENT
• Pre-malignant lesions (precancer)
– Management of pre-malignant lesions is guided
for the most part, by the degree of dysplasia
present irrespective of clinical appearance.
– Dysplasia (mild, moderate, severe)
– Non-intervention and intervention strategies may
be adopted depending on the degree of dysplasia.
Non-intervention strategies
• Patients with histologic ally proven mild or
moderate dysplastic lesion may be placed on
“non-intervention follow-up” in which case
the patient is reviewed regularly every 3-
6months and carefully examined for any
changes in the lesion which would necessitate
any further biopsy
• If the lesion appears clinically unchanged, it
should still be necessary to perform a repeat
biopsy no longer than 3yrs after the initial
biopsy
• Throughout the period of review, repeat
attempts at candida isolation and
venopuncture should be undertaken to ensure
that infection or nutritional deficiency has not
developed and advice should be given in
relation to smoking and alcohol.
Intervention Strategies
• The main method of active therapy for pre-
malignant lesions are:
– Surgical excision
– Topical cytotoxic therapy
– Cryosurgery and laser therapy
• Management often depends largely on the
experience of clinician as well as the facilities
available at the treatment centre
MALIGNANT LESIONS (oral caner)
• For many years, surgery and/or radiotherapy
has been used as a curative modality
• The aim of treatment depends on the stage of
presentation
– Early lesions: can completely be treated by surgery
or radiotherapy.
– Late lesions: a palliative treatment is advocated.
This could be in the form of radiotherapy, surgery
or both.
• Rehabilitation of patient after surgery could
be either surgical reconstruction, prosthetic
reconstruction or both.
• This is aimed at restoring esthetics, function
and speech.
• All patients must be placed on life-long review
of about 6monthly intervals during which risk
factors should be continually assessed.
CONCLUSION
• In developing countries, including Nigeria,
where resources are severely limited,
preventive measures should take priority in
the management and control of oral cancer.
• Detailed oral examination directed at
identifying precancerous lesions must always
be part of routine medical and dental
examinations particularly in patients above
the age of 35yrs
• It is also necessary that all dental and medical
practitioners should be familiar with the signs
and symptoms of oral precancer and cancer
because this would enhance early diagnosis
which is very crucial in the management of
this disease.

Contenu connexe

Tendances

Oral cancer screening
Oral cancer screeningOral cancer screening
Oral cancer screeningmrboy
 
Risk factors and prevention strategies of oral cancer
Risk factors and prevention strategies of oral cancerRisk factors and prevention strategies of oral cancer
Risk factors and prevention strategies of oral cancerDr.Priyanka Sharma
 
Oral cancer seminar
Oral cancer seminarOral cancer seminar
Oral cancer seminarkavya bhola
 
Precancerous lesions of oral cavity
Precancerous lesions of oral cavityPrecancerous lesions of oral cavity
Precancerous lesions of oral cavityDr. Bibina George
 
Mucoepidermoid carcinoma (Doctor Faris Alabeedi MSc, MMedSc, PgDip, BDS.)
Mucoepidermoid carcinoma (Doctor Faris Alabeedi MSc, MMedSc, PgDip, BDS.)Mucoepidermoid carcinoma (Doctor Faris Alabeedi MSc, MMedSc, PgDip, BDS.)
Mucoepidermoid carcinoma (Doctor Faris Alabeedi MSc, MMedSc, PgDip, BDS.)Doctor Faris Alabeedi
 
Oral Cancer Management
Oral Cancer ManagementOral Cancer Management
Oral Cancer ManagementCing Sian Dal
 
Premalignant lesions and conditions
Premalignant lesions and conditionsPremalignant lesions and conditions
Premalignant lesions and conditionsakshay shete
 
Tobacco smoking & oral cancer
Tobacco smoking & oral cancerTobacco smoking & oral cancer
Tobacco smoking & oral cancerFa Nasir
 
Epidemiology of oral cancer
Epidemiology of oral cancerEpidemiology of oral cancer
Epidemiology of oral cancerNabeela Basha
 

Tendances (20)

TNM
TNMTNM
TNM
 
SQUAMOUS CELL CARCINOMA - ORAL CANCER PPT
SQUAMOUS CELL CARCINOMA - ORAL CANCER PPTSQUAMOUS CELL CARCINOMA - ORAL CANCER PPT
SQUAMOUS CELL CARCINOMA - ORAL CANCER PPT
 
Oral cancer screening
Oral cancer screeningOral cancer screening
Oral cancer screening
 
oral cancer
oral cancer oral cancer
oral cancer
 
Risk factors and prevention strategies of oral cancer
Risk factors and prevention strategies of oral cancerRisk factors and prevention strategies of oral cancer
Risk factors and prevention strategies of oral cancer
 
Oral cancer seminar
Oral cancer seminarOral cancer seminar
Oral cancer seminar
 
02.dental caries
02.dental caries02.dental caries
02.dental caries
 
Oral squamous cell carcinoma
Oral squamous cell carcinomaOral squamous cell carcinoma
Oral squamous cell carcinoma
 
Precancerous lesions of oral cavity
Precancerous lesions of oral cavityPrecancerous lesions of oral cavity
Precancerous lesions of oral cavity
 
Leukoplakia
LeukoplakiaLeukoplakia
Leukoplakia
 
Mucoepidermoid carcinoma (Doctor Faris Alabeedi MSc, MMedSc, PgDip, BDS.)
Mucoepidermoid carcinoma (Doctor Faris Alabeedi MSc, MMedSc, PgDip, BDS.)Mucoepidermoid carcinoma (Doctor Faris Alabeedi MSc, MMedSc, PgDip, BDS.)
Mucoepidermoid carcinoma (Doctor Faris Alabeedi MSc, MMedSc, PgDip, BDS.)
 
Dental Abscess
Dental AbscessDental Abscess
Dental Abscess
 
Oral Cancer Management
Oral Cancer ManagementOral Cancer Management
Oral Cancer Management
 
Premalignant lesions and conditions
Premalignant lesions and conditionsPremalignant lesions and conditions
Premalignant lesions and conditions
 
Cancer of the oral cavity
Cancer of the oral cavityCancer of the oral cavity
Cancer of the oral cavity
 
Carcinoma buccal mucosa
Carcinoma buccal mucosaCarcinoma buccal mucosa
Carcinoma buccal mucosa
 
Oral cavity cancer
Oral cavity cancerOral cavity cancer
Oral cavity cancer
 
Dental caries
Dental cariesDental caries
Dental caries
 
Tobacco smoking & oral cancer
Tobacco smoking & oral cancerTobacco smoking & oral cancer
Tobacco smoking & oral cancer
 
Epidemiology of oral cancer
Epidemiology of oral cancerEpidemiology of oral cancer
Epidemiology of oral cancer
 

En vedette

Oral squamous cell carcinoma
Oral squamous cell carcinomaOral squamous cell carcinoma
Oral squamous cell carcinomapreethi95
 
Oral cancer pwr.pnt.
Oral cancer pwr.pnt.Oral cancer pwr.pnt.
Oral cancer pwr.pnt.kamalaiims
 
Oral cancer by Dr Amol Dumbre
Oral cancer  by Dr Amol DumbreOral cancer  by Dr Amol Dumbre
Oral cancer by Dr Amol DumbreParvez Pathan
 
Global trends in oral diseases with emphasis on 1
Global trends in oral diseases with emphasis on 1Global trends in oral diseases with emphasis on 1
Global trends in oral diseases with emphasis on 1Dr.Priyanka Sharma
 

En vedette (6)

Oral squamous cell carcinoma
Oral squamous cell carcinomaOral squamous cell carcinoma
Oral squamous cell carcinoma
 
Oral cancer pwr.pnt.
Oral cancer pwr.pnt.Oral cancer pwr.pnt.
Oral cancer pwr.pnt.
 
Oral Cancer
Oral CancerOral Cancer
Oral Cancer
 
Oral cancer by Dr Amol Dumbre
Oral cancer  by Dr Amol DumbreOral cancer  by Dr Amol Dumbre
Oral cancer by Dr Amol Dumbre
 
Global trends in oral diseases with emphasis on 1
Global trends in oral diseases with emphasis on 1Global trends in oral diseases with emphasis on 1
Global trends in oral diseases with emphasis on 1
 
Oral cancer
Oral cancerOral cancer
Oral cancer
 

Similaire à ORAL CANCER: RISK FACTORS, PREVENTION, DIAGNOSIS AND MANAGEMENT

Evaluation of Cancer Patient in OMFS
Evaluation of Cancer Patient in OMFSEvaluation of Cancer Patient in OMFS
Evaluation of Cancer Patient in OMFSHanan Shanab
 
Premalignant condition of oral cavity.pptx
Premalignant condition of oral cavity.pptxPremalignant condition of oral cavity.pptx
Premalignant condition of oral cavity.pptxPradeep Pande
 
Oral Medicine lect. 16 oral cancer of oral pathology
Oral Medicine lect. 16 oral cancer of oral pathologyOral Medicine lect. 16 oral cancer of oral pathology
Oral Medicine lect. 16 oral cancer of oral pathologyYassirBAlLuhaiby
 
Cancer of head & neck - basics
Cancer of head & neck - basicsCancer of head & neck - basics
Cancer of head & neck - basicsDr. SHEETAL KAPSE
 
Oropharyngeal cancer
Oropharyngeal cancer Oropharyngeal cancer
Oropharyngeal cancer HaroonButt17
 
Stomatitis in oncology
Stomatitis in oncologyStomatitis in oncology
Stomatitis in oncologyDr Ankur Shah
 
Cancer early screening and protection
Cancer early screening and protectionCancer early screening and protection
Cancer early screening and protectionMonkez M Yousif
 
Presentation1 oc 1
Presentation1 oc 1Presentation1 oc 1
Presentation1 oc 1Indu Krishna
 
Laryngeal Cancer
Laryngeal CancerLaryngeal Cancer
Laryngeal CancerShalu Udhay
 
Cancer of the oral cavity
Cancer of the oral cavityCancer of the oral cavity
Cancer of the oral cavityANILKUMAR BR
 
oral cancer npcdcs_dept community med
oral cancer npcdcs_dept community medoral cancer npcdcs_dept community med
oral cancer npcdcs_dept community meddrdduttaM
 
Premalignantlesions
PremalignantlesionsPremalignantlesions
PremalignantlesionsNjms Kgmc
 
Tirth modi.pptxyfcassXFIQyfdiyWFCIYwrdiy
Tirth modi.pptxyfcassXFIQyfdiyWFCIYwrdiyTirth modi.pptxyfcassXFIQyfdiyWFCIYwrdiy
Tirth modi.pptxyfcassXFIQyfdiyWFCIYwrdiymoditirth170904
 
Pre malignant lesions and conditions
Pre malignant lesions and conditionsPre malignant lesions and conditions
Pre malignant lesions and conditionsDr. Rajat Sachdeva
 
DISORDERS OF SALIVARY GLANDS.pptx
DISORDERS OF SALIVARY GLANDS.pptxDISORDERS OF SALIVARY GLANDS.pptx
DISORDERS OF SALIVARY GLANDS.pptxamanjotkaursidhu
 
Role of human papillomavirus and tumor suppressor genes
Role of human papillomavirus and tumor suppressor genesRole of human papillomavirus and tumor suppressor genes
Role of human papillomavirus and tumor suppressor genesishita1994
 

Similaire à ORAL CANCER: RISK FACTORS, PREVENTION, DIAGNOSIS AND MANAGEMENT (20)

Evaluation of Cancer Patient in OMFS
Evaluation of Cancer Patient in OMFSEvaluation of Cancer Patient in OMFS
Evaluation of Cancer Patient in OMFS
 
Premalignant condition of oral cavity.pptx
Premalignant condition of oral cavity.pptxPremalignant condition of oral cavity.pptx
Premalignant condition of oral cavity.pptx
 
Oral Medicine lect. 16 oral cancer of oral pathology
Oral Medicine lect. 16 oral cancer of oral pathologyOral Medicine lect. 16 oral cancer of oral pathology
Oral Medicine lect. 16 oral cancer of oral pathology
 
cancer2.pptx
cancer2.pptxcancer2.pptx
cancer2.pptx
 
L5,l6 esophageal tumors
L5,l6  esophageal tumorsL5,l6  esophageal tumors
L5,l6 esophageal tumors
 
Cancer of head & neck - basics
Cancer of head & neck - basicsCancer of head & neck - basics
Cancer of head & neck - basics
 
oral cancer
oral canceroral cancer
oral cancer
 
Oropharyngeal cancer
Oropharyngeal cancer Oropharyngeal cancer
Oropharyngeal cancer
 
Stomatitis in oncology
Stomatitis in oncologyStomatitis in oncology
Stomatitis in oncology
 
Cancer early screening and protection
Cancer early screening and protectionCancer early screening and protection
Cancer early screening and protection
 
Presentation1 oc 1
Presentation1 oc 1Presentation1 oc 1
Presentation1 oc 1
 
Laryngeal Cancer
Laryngeal CancerLaryngeal Cancer
Laryngeal Cancer
 
Cancer of the oral cavity
Cancer of the oral cavityCancer of the oral cavity
Cancer of the oral cavity
 
oral cancer npcdcs_dept community med
oral cancer npcdcs_dept community medoral cancer npcdcs_dept community med
oral cancer npcdcs_dept community med
 
Premalignantlesions
PremalignantlesionsPremalignantlesions
Premalignantlesions
 
Tirth modi.pptxyfcassXFIQyfdiyWFCIYwrdiy
Tirth modi.pptxyfcassXFIQyfdiyWFCIYwrdiyTirth modi.pptxyfcassXFIQyfdiyWFCIYwrdiy
Tirth modi.pptxyfcassXFIQyfdiyWFCIYwrdiy
 
ORAL CANCER.pptx
ORAL CANCER.pptxORAL CANCER.pptx
ORAL CANCER.pptx
 
Pre malignant lesions and conditions
Pre malignant lesions and conditionsPre malignant lesions and conditions
Pre malignant lesions and conditions
 
DISORDERS OF SALIVARY GLANDS.pptx
DISORDERS OF SALIVARY GLANDS.pptxDISORDERS OF SALIVARY GLANDS.pptx
DISORDERS OF SALIVARY GLANDS.pptx
 
Role of human papillomavirus and tumor suppressor genes
Role of human papillomavirus and tumor suppressor genesRole of human papillomavirus and tumor suppressor genes
Role of human papillomavirus and tumor suppressor genes
 

Plus de Soyebo Oluseye

Oral health in Pregnant women, Nursing mothers and children under Five years
Oral health in Pregnant women, Nursing mothers and children under Five yearsOral health in Pregnant women, Nursing mothers and children under Five years
Oral health in Pregnant women, Nursing mothers and children under Five yearsSoyebo Oluseye
 
Management of maxillary impacted canine
Management of maxillary impacted canineManagement of maxillary impacted canine
Management of maxillary impacted canineSoyebo Oluseye
 
Causation in epidemiology
Causation in epidemiologyCausation in epidemiology
Causation in epidemiologySoyebo Oluseye
 
Burning mouth syndrome
Burning mouth syndromeBurning mouth syndrome
Burning mouth syndromeSoyebo Oluseye
 
Measurement of diseases
Measurement of diseasesMeasurement of diseases
Measurement of diseasesSoyebo Oluseye
 
Complications of major surgery
Complications of major surgeryComplications of major surgery
Complications of major surgerySoyebo Oluseye
 

Plus de Soyebo Oluseye (9)

Oral health in Pregnant women, Nursing mothers and children under Five years
Oral health in Pregnant women, Nursing mothers and children under Five yearsOral health in Pregnant women, Nursing mothers and children under Five years
Oral health in Pregnant women, Nursing mothers and children under Five years
 
Management of maxillary impacted canine
Management of maxillary impacted canineManagement of maxillary impacted canine
Management of maxillary impacted canine
 
Lichen planus
Lichen planus Lichen planus
Lichen planus
 
Causation in epidemiology
Causation in epidemiologyCausation in epidemiology
Causation in epidemiology
 
Mandibular fracture
Mandibular fractureMandibular fracture
Mandibular fracture
 
Burning mouth syndrome
Burning mouth syndromeBurning mouth syndrome
Burning mouth syndrome
 
Measurement of diseases
Measurement of diseasesMeasurement of diseases
Measurement of diseases
 
Public health problem
Public health problemPublic health problem
Public health problem
 
Complications of major surgery
Complications of major surgeryComplications of major surgery
Complications of major surgery
 

Dernier

Monoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyMonoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyHasnat Tariq
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxDr Bilal Natiq
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 

Dernier (20)

Monoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyMonoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technology
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 

ORAL CANCER: RISK FACTORS, PREVENTION, DIAGNOSIS AND MANAGEMENT

  • 2. OUTLINE • INTRODUCTION. • DEFINITION. • EPIDEMIOLOGY. • ORAL CANCER AND PRECANCER • RISK FACTORS. • PREVENTION, DIAGNOSIS AND MANAGEMENT • CONCLUSION
  • 3. INTRODUCTION • Oral cancer is one of the ten most common malignancies in the world • In developing countries it constitutes the 3rd commonest malignancy • Sites: lips and other intra-oral sites but Para-oral sites such as the salivary glands, the oropharynx, nasopharynx and hypopharynx are not normally included
  • 4. DEFINITION • Neoplasm: an abnormal tissue that grows by cellular proliferation more rapidly than normal tissue and continues to grow after the stimuli that initiated the new growth cease. • Neoplasm show partial or complete lack of structural organization and functional coordination with the normal tissue. • Cancer – general term for malignant neoplasm
  • 5. EPIDEMIOLOGY • It is one of the ten most common malignancies in the world. • In Asia however, it accounts for over 40% of all cancers • Although there is paucity of data on the epidemiology of the disease in Nigeria, an increase in the number of oral cancer cases reporting to general specialist and teaching hospitals has been observed.
  • 6. • Over 80% of the malignant neoplasm of the oro- facial region are squamous cell carcinomas of the oral mucosa, tongue and lip. • It usually occurs in people above 40yrs of age though, in high prevalent areas such as India, Brazil, New Guinea, France and in Western Europe, where the teenagers use oral snuff, the incidence of oral cancer has been recorded in people below the ages of 35yrs. • Males are often affected more than females
  • 7. ORAL CANCER AND PRECANCER • Oral cancer: lips and other intra-oral sites. – In the biology of oral cancer, it is now accepted that series of discrete events take place which eventually summate to form invasive neoplasm – During oral carcinogenesis, aetiological factors may damage cells at the level of DNA – We can therefore assume that most if not all oral cancers develop from cells which have survived a succession of insults at the gene level and that in a proportion of cases there may be distinguishing at the clinical and histological level which indicate precancerous change
  • 8. • The WHO defined a precancerous lesion as – “a generalized state associated with a significant increased risk of cancer” • Leukoplakia and Erythroplakia constitute the important precancerous lesions
  • 9. • Leukoplakia: a white patch or plaque that cannot be rubbed off and cannot be characterized clinically or histologically as any other disease. – It must in addition not be associated with any physical or chemical causative agent except the use of tobacco. • Erythroplakia: a red patch that cannot be characterized histologically or clinically as due to any other condition. – It is far less common than leukoplakia but it has a higher malignant potential.
  • 10. RISK AREAS • Floor of the mouth • Lateral border of the tongue • Lower buccal sulcus • Alveolus • Angle of the mouth
  • 11.
  • 12. PRECANCEROUS LESIONS PRECANCEROUS CONDITIONS Leukoplakia Erythroplakia Syphilis Sideropenic dysphagia Submucous fibrosis Lichen planus Discoid lupus erythematosus Actinic keratosis Sublingual keratosis
  • 13. RISK FACTORS • Tobacco • Alcohol • Diet and Nutrition • Ultraviolet light • Fungal and Viral infection • Habits • Chronic Irritation • Immunodeficiency/ Suppression • Occupational Risk
  • 14. TOBACCO • Major source of intra-oral carcinogen. • All forms of tobacco consumption have been linked. – South east Asia: bethel quid – North Africa and Middle East: a mixture of Tobacco and lime water or oil called naswar or nash – It could be held in the mouth – Smoked in crude cigars or factory made cigarettes • Carcinogens in tobacco: Nitrosamine (nicotine), the polycyclic aromatic hydrocarbons (3,4-benzopyrene)
  • 15. ALCOHOL • 2nd major risk factor • Associated with cancer of the floor of the mouth and tongue. • Excess consumption of EVERY TYPE of alcohol (including “hard” liquor, wine, and Beer) raises the risk status of oral cancer • Potentiates the effects of tobacco • Mechanism(s) • Dehydrating effects of alcohol on the mucosa, • increasing mucosal permeability, • Irritation of mucosa • and it also acts as a solvent for carcinogens (especially those in tobacco)
  • 16. DIET AND NUTRITION • Deficiency of vitamin C, vitamin E , beta carotene is a precursor of vitamin A and vitamin A has been linked to oral cancer. • Adequate consumption of raw vegetables and fresh fruits gives a lower risk of oral and pharyngeal cancer. • Mechanism: Atrophy of oral mucosa membrane. • This render them more susceptible to carcinogens.
  • 17. ULTRAVIOLET LIGHT • Causes – Basal cell carcinoma of the skin – carcinoma of the vermilion border of the lips especially in people with outdoor occupation. • Affects men more.
  • 18. FUNGAL INFECTION • Candida albicans has been implicated in oral squamous cell carcinoma. • Also found in oral red and white patches with malignant potentials. • Mechanisms – Production of enzymes which produce genotoxic metabolites – Its hyphae carrying oncogenes like Ras
  • 19. VIRAL INFECTION • Human papilloma virus types 16 and 18 • Epstein Barr virus (naso-pharyngeal carcinoma)
  • 20. HABITS • Chewing of betel quids and areca nuts, especially when mixed with tobacco increases the risk of developing oral cancer. • Areca has been associated with the development of Submucous fibrosis • Use of clay pipe has been associated with lip cancer (thermal irritation)
  • 21. CHRONIC IRRITATION • It is possible that chronic trauma, in addition to other carcinogens, may promote the transformation of epithelial cells. • Dental calculus, ill fitting dentures, jagged edges of restorations may play a role in localizing the site of tumor development.
  • 22. IMMUNE DEFICIENCY/ SUPPRESSION • It could b drug induced or as a result of HIV infection which could render patients susceptible to oncogenic viruses • However a definite relationship between immune suppression and oral cancer is yet to be established.
  • 23. OCCUPATIONAL RISK • Plays a minor role • Exposure to the following have been associated with oropharyngeal and laryngeal cancer; – Cement – Coal products – Wood dust – Organic chemicals – Nickel dust • Occupational exposure to Ultraviolet rays from sunlight has been associated with cancer of the lips
  • 24. DIAGNOSIS • Diagnosis of oral cancer and precancer depends on the medical and dental history and clinical examination supplemented by investigations • Any chronic oral lesion should be regarded with suspicion especially in an older patient or associated with any of the precancerous lesions and conditions outlined below • Extra caution must also be taken if lesion is indurated, fixed, attached to the underlying tissue, associated with lymphadenopathy.
  • 25. Prognostic factors • Tumor size: <2cm • Depth of infiltration: <5mm • Site : lips > oral cavity > oropharynx • Lymph nodes: presence of clinically positive or fixed lymph nodes gives worse prognosis
  • 26. PREVENTION. • Prevention involves interventions aimed at eliminating, eradicating or minimizing the impact of the disease • PRIMORDIAL • Avoid the emergence and establishment of the patterns of living that are known to contribute to an elevated risk of disease
  • 27. • PRIMARY: Reduce the incidence of cancer and precancer.It is aimed reducing the number of new cases. – Discourage smoking and alcohol consumption – Encourage good oral hygiene – Encourage balanced diet – Use of hat in sunlight for farmers – Wearing of facemasks for factory workers involved with chemicals and metals – Health education
  • 28. PREVENTION. • SECONDARY: aimed at detection of cancer at an early stage • Early detection, especially at the precancerous stage, offers a better prognosis with a better chance of cure. › Public education on early signs and self examination › Screening
  • 29. PREVENTION. • TERTIARY: Treat late stage of disease and complications
  • 30. MANAGEMENT • Pre-malignant lesions (precancer) – Management of pre-malignant lesions is guided for the most part, by the degree of dysplasia present irrespective of clinical appearance. – Dysplasia (mild, moderate, severe) – Non-intervention and intervention strategies may be adopted depending on the degree of dysplasia.
  • 31. Non-intervention strategies • Patients with histologic ally proven mild or moderate dysplastic lesion may be placed on “non-intervention follow-up” in which case the patient is reviewed regularly every 3- 6months and carefully examined for any changes in the lesion which would necessitate any further biopsy • If the lesion appears clinically unchanged, it should still be necessary to perform a repeat biopsy no longer than 3yrs after the initial biopsy
  • 32. • Throughout the period of review, repeat attempts at candida isolation and venopuncture should be undertaken to ensure that infection or nutritional deficiency has not developed and advice should be given in relation to smoking and alcohol.
  • 33. Intervention Strategies • The main method of active therapy for pre- malignant lesions are: – Surgical excision – Topical cytotoxic therapy – Cryosurgery and laser therapy • Management often depends largely on the experience of clinician as well as the facilities available at the treatment centre
  • 34. MALIGNANT LESIONS (oral caner) • For many years, surgery and/or radiotherapy has been used as a curative modality • The aim of treatment depends on the stage of presentation – Early lesions: can completely be treated by surgery or radiotherapy. – Late lesions: a palliative treatment is advocated. This could be in the form of radiotherapy, surgery or both.
  • 35. • Rehabilitation of patient after surgery could be either surgical reconstruction, prosthetic reconstruction or both. • This is aimed at restoring esthetics, function and speech. • All patients must be placed on life-long review of about 6monthly intervals during which risk factors should be continually assessed.
  • 36. CONCLUSION • In developing countries, including Nigeria, where resources are severely limited, preventive measures should take priority in the management and control of oral cancer. • Detailed oral examination directed at identifying precancerous lesions must always be part of routine medical and dental examinations particularly in patients above the age of 35yrs
  • 37. • It is also necessary that all dental and medical practitioners should be familiar with the signs and symptoms of oral precancer and cancer because this would enhance early diagnosis which is very crucial in the management of this disease.